Schedule 13G ownership disclosure

AILERON THERAPEUTICS INC

Security class unavailable · CUSIP: 00887A105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,542,288
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137774-19-000101
Form type
SC 13G/A
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Nov 12, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub